MAI Wealth Advisors »

Alaunos Therapeutics shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Alaunos Therapeutics (TCRT) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Alaunos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Alaunos Therapeutics held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alaunos Therapeutics by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $12 6 2.00

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Amazon Call Call Option (Principal) (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr S&p 500 Val Etf (IVE)
Broadcom Call Call Option (Principal) (AVGO)
Alphabet Call Call Option (Principal) (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for MAI Wealth Advisors

Top funds holding Alaunos Therapeutics

BlackRock
Vanguard Group
Geode Capital Management
Morgan Stanley
Tower Research Capital
UBS Group
Advisor Group Holdings
Atlantic Trust
Royal Bank of Canada
Wells Fargo & Company
Ronald Blue Trust
Steward Partners Investment Advisory
Federation des caisses Desjardins du Quebec
Barclays
Asset Dedication

View all funds holding Alaunos Therapeutics